Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 256

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age‐dependent manner

Open access
Deane, Kevin D., O'Donnell, Colin I., Hueber, Wolfgang, Majka, Darcy S., Lazar, Ann A., Derber, Lezlie A., Gilliland, William R., Edison, Jess D., Norris, Jill M., Robinson, William H., Holers, V. Michael·2010·Arthritis & Rheumatism

Abstract

Objective: To evaluate levels of biomarkers in preclinical rheumatoid arthritis (RA) and to use elevated biomarkers to develop a model for the prediction of time to future diagnosis of seropositive RA. Methods: Stored samples obtained from 73 military cases with seropositive RA prior to RA diagnosis and from controls (mean 2.9 samples per case; samples collected a mean of 6.6 years prior to diagnosis) were tested for rheumatoid factor (RF) isotypes, anti–cyclic citrullinated peptide (anti‐CCP) antibodies, 14 cytokines and chemokines (by bead‐based assay), and C‐reactive protein (CRP). Results: Preclinical positivity for anti‐CCP and/or ≥2 RF isotypes was >96% specific for future RA. In preclinical RA, levels of the following were positive in a significantly greater proportion of RA cases versus controls: interleukin‐1α (IL‐1α), IL‐1β, IL‐6, IL‐10, IL‐12p40, IL‐12p70, IL‐15, fibroblast growth factor 2, flt‐3 ligand, tumor necrosis factor α, interferon‐γ–inducible 10‐kd protein, granulocyte–macrophage colony‐stimulating factor, and CRP. Also, increasing numbers of elevated cytokines/chemokines were present in cases nearer to the time of diagnosis. RA patients who were ≥40 years old at diagnosis had a higher proportion of samples positive for cytokines/chemokines 5–10 years prior to diagnosis than did patients who were <40 years old at diagnosis ( P < 0.01). In regression modeling using only case samples positive for autoantibodies highly specific for future RA, increasing numbers of cytokines/chemokines were predictive of decreased time to diagnosis, and the predicted time to diagnosis based on cytokines/chemokines was longer in older compared with younger cases. Conclusion: Levels of autoantibodies, cytokines/chemokines, and CRP are elevated in the preclinical period of RA development. In preclinical autoantibody‐positive cases, the number of elevated cytokines/chemokines is predictive of the time of diagnosis of future RA in an age‐dependent manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.27638

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 256

Metadata

Authors
Deane, K. D., O'Donnell, C. I., Hueber, W., Majka, D. S., Lazar, A. A., Derber, L. A., Gilliland, W. R., Edison, J. D., Norris, J. M., Robinson, W. H., & Holers, V. M.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2010-10-29
Volume
62
Issue
11
Pages
3161-3172
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2128619333
Cited by
256
References
31
FWCI
9.44
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age‐dependent manner. https://app.cochat.ai/papers/10.1002/art.27638
The paper
Deane, K. D., O'Donnell, C. I., Hueber, W., Majka, D. S., Lazar, A. A., Derber, L. A., Gilliland, W. R., Edison, J. D., Norris, J. M., Robinson, W. H., & Holers, V. M. (2010). The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age‐dependent manner. Arthritis & Rheumatism. https://doi.org/10.1002/art.27638

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.